Gene Therapy

tracking system home

submission guidelines

reviewer instructions

help

journal home

Welcome to Gene Therapy's online manuscript submission and tracking system. Please be sure that your browser is set to accept cookies, our tracking system requires them for proper operation. See Tips for more information. If you are a first time user please read our Instructions to Authors or Reviewers. Experienced users please remember that passwords are case sensitive.

If you experience any problems, please contact the Platform Support Helpdesk.

Please note: As of the 1st November 2012, a new combined page/colour charge structure will be implemented for Gene Therapy – please refer to the instructions to authors for more information.

Forgot my login details

Open access
Gene Therapy is a hybrid journal. Authors can choose to publish using either the subscription publishing route OR via immediate gold Open Access through payment of an article-processing charge (APC).

Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal's standard licensing terms will need to be accepted, including self-archiving policies. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.